Targeting the Mevalonate Pathway to Overcome Acquired Anti-HER2 Treatment Resistance in Breast Cancer.
Antineoplastic Agents
/ pharmacology
Apoptosis
/ drug effects
Breast Neoplasms
/ drug therapy
Cell Line, Tumor
Drug Resistance, Neoplasm
Female
Humans
Lapatinib
/ pharmacology
Mechanistic Target of Rapamycin Complex 1
/ genetics
Mevalonic Acid
/ metabolism
Phosphorylation
Receptor, ErbB-2
/ antagonists & inhibitors
Signal Transduction
Trastuzumab
/ pharmacology
Journal
Molecular cancer research : MCR
ISSN: 1557-3125
Titre abrégé: Mol Cancer Res
Pays: United States
ID NLM: 101150042
Informations de publication
Date de publication:
11 2019
11 2019
Historique:
received:
23
07
2019
revised:
08
08
2019
accepted:
14
08
2019
pubmed:
20
8
2019
medline:
29
7
2020
entrez:
18
8
2019
Statut:
ppublish
Résumé
Despite effective strategies, resistance in HER2
Identifiants
pubmed: 31420371
pii: 1541-7786.MCR-19-0756
doi: 10.1158/1541-7786.MCR-19-0756
pmc: PMC6825570
mid: NIHMS1537921
doi:
Substances chimiques
Antineoplastic Agents
0
Lapatinib
0VUA21238F
ERBB2 protein, human
EC 2.7.10.1
Receptor, ErbB-2
EC 2.7.10.1
Mechanistic Target of Rapamycin Complex 1
EC 2.7.11.1
Trastuzumab
P188ANX8CK
Mevalonic Acid
S5UOB36OCZ
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
2318-2330Subventions
Organisme : NCI NIH HHS
ID : P30 CA016672
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA125123
Pays : United States
Organisme : NCI NIH HHS
ID : P50 CA058183
Pays : United States
Organisme : NCI NIH HHS
ID : P50 CA186784
Pays : United States
Informations de copyright
©2019 American Association for Cancer Research.
Références
J Cancer. 2016 Jan 10;7(3):314-23
pubmed: 26918045
Hepatology. 2016 Jan;63(1):159-72
pubmed: 26389641
Cell Death Dis. 2013 Apr 04;4:e568
pubmed: 23559002
J Cell Biochem. 2018 Sep 6;:null
pubmed: 30191610
Cancer Cell. 2010 Apr 13;17(4):348-61
pubmed: 20385360
Biochem Biophys Res Commun. 1999 Jul 14;260(3):699-706
pubmed: 10403829
Nat Commun. 2017 Oct 11;8(1):864
pubmed: 29021522
Biochem Biophys Res Commun. 1999 Oct 14;264(1):108-11
pubmed: 10527849
J Biol Chem. 2008 Oct 10;283(41):27534-46
pubmed: 18640976
Nat Rev Cancer. 2011 Oct 24;11(11):775-91
pubmed: 22020205
Breast Cancer Res. 2010;12(6):214
pubmed: 21176176
Breast Cancer Res. 2016 Jun 01;18(1):58
pubmed: 27246191
Proc Natl Acad Sci U S A. 2010 Aug 24;107(34):15051-6
pubmed: 20696928
Nature. 1998 Dec 10;396(6711):580-4
pubmed: 9859993
Cancer Lett. 2013 Feb 1;329(1):9-16
pubmed: 22960596
Clin Cancer Res. 2011 Mar 15;17(6):1351-61
pubmed: 21138857
Cell. 2014 Jul 3;158(1):185-197
pubmed: 24954535
Proc Natl Acad Sci U S A. 2014 Jan 7;111(1):E89-98
pubmed: 24367099
Mol Biol Cell. 2015 Nov 5;26(22):3946-53
pubmed: 26337386
J Clin Oncol. 2013 May 10;31(14):1726-31
pubmed: 23569315
J Pharmacol Exp Ther. 2001 Jun;297(3):861-7
pubmed: 11356905
Cell. 2014 Jul 3;158(1):171-84
pubmed: 24954536
Nature. 2011 Jun 08;474(7350):179-83
pubmed: 21654799
Breast Cancer Res. 2011;13(6):R121
pubmed: 22123186
Mol Cancer Ther. 2006 May;5(5):1087-98
pubmed: 16731740
Breast Cancer Res. 2011 Aug 31;13(4):R84
pubmed: 21884573
Lancet Oncol. 2017 Apr;18(4):545-554
pubmed: 28238593
PLoS One. 2018 May 15;13(5):e0197422
pubmed: 29763460
J Biol Chem. 2010 Nov 26;285(48):37159-69
pubmed: 20858893
Cell. 2007 Sep 21;130(6):1120-33
pubmed: 17889654
Genes Dev. 2010 Jan 1;24(1):72-85
pubmed: 20048001
Cancer Biol Ther. 2015;16(3):402-11
pubmed: 25692408
Cancer Res. 2006 Sep 1;66(17):8707-14
pubmed: 16951186
J Biol Chem. 2003 Aug 29;278(35):33334-41
pubmed: 12807903
Physiol Rev. 2014 Oct;94(4):1287-312
pubmed: 25287865
Nat Cell Biol. 2014 Apr;16(4):357-66
pubmed: 24658687
Genes Dev. 2008 Jul 15;22(14):1962-71
pubmed: 18579750
Breast Cancer Res Treat. 2012 Dec;136(3):683-92
pubmed: 23089982
Biochem Pharmacol. 1993 Jun 9;45(11):2203-8
pubmed: 8517861
Oncotarget. 2016 Apr 19;7(16):21064-75
pubmed: 27027448
Chem Biol. 2009 Aug 28;16(8):882-92
pubmed: 19716478
J Biol Chem. 2004 Aug 6;279(32):33079-84
pubmed: 15155733
Exp Biol Med (Maywood). 2004 Jul;229(7):567-85
pubmed: 15229351
Oncogene. 2017 Aug 10;36(32):4573-4584
pubmed: 28368399
Nat Rev Mol Cell Biol. 2011 Jan;12(1):21-35
pubmed: 21157483
Nature. 1990 Feb 1;343(6257):425-30
pubmed: 1967820
Annu Rev Med. 2015;66:111-28
pubmed: 25587647
Biochim Biophys Acta. 2013 Aug;1830(8):4053-64
pubmed: 23583370
Proc Natl Acad Sci U S A. 2012 Sep 11;109(37):E2441-50
pubmed: 22891335
Breast. 2017 Aug;34 Suppl 1:S19-S26
pubmed: 28687441
Crit Rev Oncol Hematol. 1996 Apr;22(3):197-212
pubmed: 8793275
Breast Cancer Res Treat. 2017 Jul;164(1):1-11
pubmed: 28432513